BeStock  
Stocks › Biotechnology › STTK

Shattuck Labs STTK

US equityMarket cap rank #3632Biotechnology
$4.46 −$0.09 (-1.98%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $4.47 +0.22%
Open$4.48
Prev close$4.55
Day range$4.42 – $4.68
Volume1.03M
Market cap$454.22M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership85.3%+1.81 pts vs. prior quarter
Institutions holding140+16 vs. prior quarter
Insider trades (recent)34 buys / 16 sellsNet buying
Short interest10.71% of floatDays to cover 12.0 · as of 30 Oct 2026
Short-sale volume share23.0%5-day average of daily volume

Short-sale volume as % of daily volume

12%21%30%39%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$2.95M (6 inflow days, 14 outflow days).

Net flow by order size, last 20 sessions

−$1.7MSuper−$1.2MBig−$1.0MMid−$962.7KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 41.2% of shares outstanding.

Largest holders

  • T. Rowe Price Group, Inc.15.78%
  • Adage Capital Management, L.P.7.98%
  • OrbiMed Advisors LLC6.19%
  • Prosight Management, LP5.85%
  • BlackRock5.39%
  • Redmile Group, LLC5.14%
  • Frazier Life Sciences Management, LP3.68%
  • Nextbio Capital Management LP3.66%

By investor type

  • Mutual Fund41.32%
  • Hedge Fund27.58%
  • VC/PE Fund13.51%
  • Individual/Insider6.86%
  • Family Office/Trust1.57%
  • Public Company0.95%
  • Private Company0.23%
  • Insurance Company0.08%

Reported short interest has risen from 5.98% to 10.71% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
State Street Global Advisors Mutual Fund 2026/Q3 +2,409,389 3.4%
BlackRock Mutual Fund 2026/Q3 +1,403,648 5.2%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +393,696 1.9%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +379,816 1.3%
Pinnacle Associates, Ltd. Mutual Fund 2026/Q3 +228,337 2.1%
UBS Asset Management Mutual Fund 2026/Q3 +192,170 0.2%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +174,652 3.3%
Connor, Clark & Lunn Investment Management Ltd. Mutual Fund 2026/Q3 +173,086 0.5%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +4,425,270 15.8%
Frazier Life Sciences Management, LP VC/PE Fund 2026/Q3 +3,750,000 3.7%
Deep Track Capital, LP VC/PE Fund 2026/Q3 +3,706,734 3.6%
Adage Capital Management, L.P. Hedge Fund 2026/Q3 +3,477,222 8.0%
BlackRock Mutual Fund 2026/Q3 +3,425,004 3.9%
Wellington Management Group Mutual Fund 2026/Q3 +1,767,938 1.7%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +1,069,516 3.7%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
5 Jul 2026 Abhinav Shukla Chief Technology Officer Derivative Exercise and Retained +12,153 $3.57 75,295
1 Jul 2026 Abhinav Shukla Chief Technology Officer Derivative Exercise and Sale -410 $7.01 75,295
30 Jun 2026 Abhinav Shukla Chief Technology Officer Intent to Sell (Form 144) -100 $7.07 –
30 Jun 2026 Abhinav Shukla Chief Technology Officer Derivative Exercise and Sale -23,465 $7.08 63,143
29 Jun 2026 Arunthathy Pandite Chief Medical Officer Automatic Disposition -30,000 $7.01 136,219
29 Jun 2026 Abhinav Shukla Chief Technology Officer Intent to Sell (Form 144) -23,365 $7.08 –
10 Jun 2026 OrbiMed Advisors LLC Open Market Derivative Acquisiti +1,250,000 $0.00 5,303,908
8 Jun 2026 Clay Siegall Independent Director Open Market Acquisition +62,500 $4.00 318,608
7 Jun 2026 OrbiMed Advisors LLC Other Derivative Acquisition +18,439,788 $0.00 5,095,575
7 Jun 2026 Mona Ashiya Independent Director Other Derivative Acquisition +18,439,788 $0.00 5,095,575
28 May 2026 Clay Siegall Independent Director Other Derivative Acquisition +81,000 $5.95 81,000
28 May 2026 Neil W. Gibson Independent Director Other Derivative Acquisition +81,000 $5.95 81,000
28 May 2026 Mona Ashiya Independent Director Other Derivative Acquisition +81,000 $5.95 81,000
28 May 2026 George Golumbeski Independent Chairperson Other Derivative Acquisition +81,000 $5.95 81,000
28 May 2026 Helen Boudreau Independent Director Other Derivative Acquisition +81,000 $5.95 81,000
28 May 2026 Daniel Baker Independent Director Other Derivative Acquisition +81,000 $5.95 81,000
21 May 2026 Clay Siegall Independent Director Derivative Exercise and Retained +128,054 $1.08 256,108
20 May 2026 Abhinav Shukla Chief Technology Officer Derivative Exercise and Retained +5,122 $1.08 63,143
14 May 2026 Stephen Stout General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer Other Acquisition +12,805 $1.08 62,866
11 May 2026 Taylor Schreiber Chief Executive Officer Derivative Exercise and Retained +25,610 $1.08 2,732,972

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 10,745,702 10.7% 12.0
15 Oct 2026 10,440,338 10.4% 7.2
30 Sep 2026 10,947,042 10.9% 6.0
15 Sep 2026 6,808,662 6.8% 8.4
31 Aug 2026 5,571,195 5.6% 7.6
14 Aug 2026 6,006,320 6.0% 5.8

Discussion

No comments yet — be the first to weigh in on STTK.

Sign in to join the discussion.

Scroll to Top